Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis

Stem Cell Research

Volumn 9, Issue 2, 2012, Pages 77-86

  Sun, Hongliang ^a   Tsai, Ying ^a   Nowak, Irena ^a   Liesveld, Jane ^a   Chen, Yuhchyau ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; ELTROMBOPAG; FIBRINOGEN RECEPTOR; PROTEIN KINASE B; RECOMBINANT THROMBOPOIETIN; STAT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL EXPANSION; THROMBOCYTE; UMBILICAL CORD BLOOD; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; BENZOATES; BLOOD PLATELETS; BONE MARROW CELLS; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; FETAL BLOOD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; HYDRAZINES; LEUKOCYTES; MICE; MICE, SCID; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; RECEPTORS, THROMBOPOIETIN; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR;

MUS; PAN;

EID: 84861942513     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.05.001     Document Type: Article

References (49)

1. Akahori H., Shibuya K., Ozai M., Ida M., Kabaya K., Kato T., Miyazaki H. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice. Stem Cells 1996, 14:678-689.
2. Ballen K.K., Spitzer T.R., Yeap B.Y., McAfee S., Dey B.R., Attar E., Haspel R., Kao G., Liney D., Alyea E., Lee S., Cutler C., Ho V., Soiffer R., Antin J.H. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol. Blood Marrow Transplant. 2007, 13:82-89.
3. Barker J.N., Krepski T.P., DeFor T.E., Davies S.M., Wagner J.E., Weisdorf D.J. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol. Blood Marrow Transplant. 2002, 8:257-260.
4. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., Miller J.S., Wagner J.E. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1919.
5. Basser R.L., O'Flaherty E., Green M., Edmonds M., Nichol J., Menchaca D.M., Cohen B., Begley C.G. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 2002, 99:2599-2602.
6. Bhatia M., Wang J.C., Kapp U., Bonnet D., Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5320-5325.
7. Borge O.J., Ramsfjell V., Cui L., Jacobsen S.E. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+ CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood 1997, 90:2282-2292.
8. Brunstein C.G., Barker J.N., Weisdorf D.J., DeFor T.E., Miller J.S., Blazar B.R., MCGlave P.B., Wagner J.E. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110:3064-3070.
9. Bussel J.B., Cheng G., Saleh M.N., Psaila B., Kovaleva L., Meddeb B., Kloczko J., Hassani H., Mayer B., Stone N.L., Arning M., Provan D., Jenkins J.M. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. New Engl. J. Med. 2007, 357:2237-2247.
10. Bussel J.B., Provan D., Shamsi T., Cheng G., Psaila B., Kovaleva L., Salama A., Jenkins J.M., Roychowdhury D., Mayer B., Stone N., Arning M. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 2009, 373:641-648.
11. Chao N.J., Emerson S.G., Weinberg K.I. Stem cell transplantation (cord blood transplants). Hematology Am. Soc. Hematol. Educ. Program 2004, 354-371.
12. Eltrombopag Investigator Brochure, 2012.
13. Erhardt J.A., Erickson-Miller C.L., Aivado M., Abboud M., Pillarisetti K., Toomey J.R. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function. Exp. Hematol. 2009, 37:1030-1037.
14. Erickson-Miller C.L., DeLorme E., Tian S.S., Hopson C.B., Stark K., Giampa L., Valoret E.I., Duffy K.J., Luengo J.L., Rosen J., Miller S.G., Dillon S.B., Lamb P. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist. Exp. Hematol. 2005, 33:85-93.
15. Erickson-Miller C.L., Delorme E., Tian S.S., Hopson C.B., Landis A.J., Valoret E.I., Sellers T.S., Rosen J., Miller S.G., Luengo J.I., Duffy K.J., Jenkins J.M. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells 2009, 27:424-430.
16. Farese A.M., Hunt P., Grab L.B., MacVittie T.J. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J. Clin. Invest. 1996, 97:2145-2151.
17. Fox N., Priestley G., Papayannopoulou T., Kaushansky K. Thrombopoietin expands hematopoietic stem cells after transplantation. J. Clin. Invest. 2002, 110:389-394.
18. Fukushima-Shintani M., Suzuki K., Iwatsuki Y., Abe M., Sugasawa K., Hirayama F., Kawasaki T., Nakahata T. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist. Eur. J. Haematol. 2009, 82:247-254.
19. Gluckman E., Rocha V., Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplant. Transfus. Clin. Biol. 2001, 8:146-154.
20. Grossmann A., Lenox J., Deisher T.A., Ren H.P., Humes J.M., Kaushansky K., Sprugel K.H. Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice. Blood 1996, 88:3363-3370.
21. Grossmann A., Lenox J., Ren H.P., Humes J.M., Forstrom J.W., Kaushansky K., Sprugel K.H. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp. Hematol. 1996, 24:1238-1246.
22. Inagaki K., Oda T., Naka Y., Shinkai H., Komatsu N., Iwamura H. Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities. Blood 2004, 104:58-64.
23. Jenkins J.M., Williams D., Deng Y., Uhl J., Kitchen V., Collins D., Erickson-Miller C.L. Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 2007, 109:4739-4741.
24. Kaushansky K., Lin N., Grossmann A., Humes J., Sprugel K.H., Broudy V.C. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp. Hematol. 1996, 24:265-269.
25. Kernan N.A., Bartsch G., Ash R.C., Beatty P.G., Champlin R., Filipovich A., Gajewski J., Hansen J.A., Henslee-Downey J., McCullough J. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl. J. Med. 1993, 328:593-602.
26. Kobayashi M., Laver J.H., Kato T., Miyazaki H., Ogawa M. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 1996, 88:429-436.
27. Koestenbauer S., Zisch A., Dohr G., Zech N.H. Protocols for hematopoietic stem cell expansion from umbilical cord blood. Cell Transplant. 2009, 18:1059-1068.
28. Ku H., Yonemura Y., Kaushansky K., Ogawa M. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1996, 87:4544-4551.
29. Larochelle A., Vormoor J., Hanenberg H., Wang J.C., Bhatia M., Lapidot T., Moritz T., Murdoch B., Xiao X.L., Kato I., Williams D.A., Dick J.E. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 1996, 2:1329-1337.
30. Li J., Yang C., Xia Y., Bertino A., Glaspy J., Roberts M., Kuter D.J. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 2001, 98:3241-3248.
31. Luens K.M., Travis M.A., Chen B.P., Hill B.L., Scollay R., Murray L.J. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+ Thy-1+ Lin- cells with preserved ability to engraft SCID-hu bone. Blood 1998, 91:1206-1215.
32. Majka M., Janowska-Wieczorek A., Ratajczak J., Kowalska M.A., Vilaire G., Pan Z.K., Honczarenko M., Marquez L.A., Poncz M., Ratajczak M.Z. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood 2000, 96:4142-4151.
33. Majka M., Ratajczak J., Villaire G., Kubiczek K., Marquez L.A., Janowska-Wieczorek A., Ratajczak M.Z. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Exp. Hematol. 2002, 30:751-760.
34. McHutchison J.G., Dusheiko G., Shiffman M.L., Rodriguez-Torres M., Sigal S., Bourliere M., Berg T., Gordon S.C., Campbell F.M., Theodore D., Blackman N., Jenkins J., Afdhal N.H. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N. Engl. J. Med. 2007, 357:2227-2236. TPL102357 Study Group.
35. Misawa M., Kai S., Okada M., Nakajima T., Nomura K., Wakae T., Toda A., Itoi H., Takatsuta H., Itsukuma T., Nishioka K., Fujimori Y., Ogawa H., Hara H. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. Int. J. Hematol. 2006, 83:74-79.
36. Nakamura T., Miyakawa Y., Miyamura A., Yamane A., Suzuki H., Ito M., Ohnishi Y., Ishiwata N., Ikeda Y., Tsuruzoe N. A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis. Blood 2006, 107:4300-4307.
37. Neelis K.J., Dubbelman Y.D., Qingliang L., Thomas G.R., Eaton D.L., Wagemaker G. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp. Hematol. 1997, 25:1084-1093.
38. Nishino T., Miyaji K., Ishiwata N., Arai K., Yui M., Asai Y., Nakauchi H., Iwama A. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-Mpl. Exp. Hematol. 2009, 37(1364-1377):e4.
39. Nogami W., Yoshida H., Koizumi K., Yamada H., Abe K., Arimura A., Yamane N., Takahashi K., Yamane A., Oda A., Tanaka Y., Takemoto H., Ohnishi Y., Ikeda Y., Miyakawa Y. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica 2008, 93:1495-1504.
40. Petzer A.L., Zandstra P.W., Piret J.M., Eaves C.J. Differential cytokine effects on primitive (CD34+ CD38-) human hematopoietic cells: novel responses to flt3-ligand and thrombopoietin. J. Exp. Med. 1996, 183:2551-2558.
41. Qian H., Buza-Vidas N., Hyland C.D., Jensen C.T., Antonchuk J., Mansson R., Thoren L.A., Ekblom M., Alexander W.S., Jascobsen S.E. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 2007, 1:671-684.
42. Ramsfjell V., Borge O.J., Cui L., Jacobsen S.E. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha. J. Immunol. 1997, 158:5169-5177.
43. Rocha V., Mohty M., Gluckman E., Rio B. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr. Opin. Oncol. 2009, 21(Suppl. 1):S31-S34. Eurocrod; Reduced Intensity Conditioning Subcommittee of the Acute Leukaemia Working Party; French Society of Bone Marrow Transplantation and Cellular Therapy.
44. Rocha V., Wagner J.E., Sobocinski K.A., Klein J.P., Zhang M.J., Horowitz M.M., Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N. Engl. J. Med. 2000, 342:1846-1854. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
45. Sitnicka E., Lin N., Priestley G.V., Fox N., Broudy V.C., Wolf N.S., Kaushansky K. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 1996, 87:4998-5005.
46. Solar G.P., Kerr W.G., Zeigler F.C., Hess D., Donahue C., de Sauvage F.J., Eaton D.L. Role of c-Mpl in early hematopoiesis. Blood 1998, 92:4-10.
47. Will B., Kawahara M., Luciano J.P., Bruns I., Parekh S., Erickson-Miller C.L., Aivado M.A., Verma A., Steidl U. Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. Blood 2009, 114:3899-3908.
48. Yoshihara H., Arai F., Hosokawa K., Hagiwara T., Takubo K., Nakamura Y., Gomei Y., Iwasaki H., Matsuoka S., Miyamoto K., Miyazaki H., Takahashi T., Suda T. Thrombopoietin/Mpl signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007, 1:685-697.
49. Young J.C., Bruno E., Luens K.M., Wu S., Backer M., Murray L.J. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+ Thy-1+ Lin- primitive progenitor cells. Blood 1996, 88:1619-1631.